New Zealand markets closed

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
57.60-0.21 (-0.36%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close57.81
Open57.81
Bid0.00 x 2900
Ask0.00 x 1300
Day's range57.44 - 58.09
52-week range56.66 - 69.75
Volume6,884,484
Avg. volume9,456,564
Market cap127.994B
Beta (5Y monthly)0.63
PE ratio (TTM)N/A
EPS (TTM)-2.26
Earnings date27 Oct 2021
Forward dividend & yield1.96 (3.40%)
Ex-dividend date30 Sep 2021
1y target est74.63
  • Motley Fool

    2 Upcoming FDA Approval Decisions That Investors Should Really Watch

    In this Motley Fool Live video recorded on Oct. 13, Fool contributors Keith Speights and Brian Orelli discuss two upcoming U.S. Food and Drug Administration (FDA) approval decisions that investors should keep an eye on. Keith Speights: Brian, on another note, the FDA is set to make several important approval decisions in the fourth quarter. Brian Orelli: Biomarin (NASDAQ: BMRN) has one coming up on Nov. 20.

  • GlobeNewswire

    BMY, HNST, HYZN, SAM INVESTOR ALERT BY CLAIMSFILER: Pending Lead Plaintiff Deadline in Class Action Lawsuits

    NEW ORLEANS, Oct. 22, 2021 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: The Boston Beer Company, Inc. (SAM)Class Period: 4/22/2021 - 9/8/2021 Lead Plaintiff Motion Deadline: November 15, 2021SECURITIES FRAUD To learn more, visit https://claimsfiler.com/cases/nyse-sam/ The Honest Company, Inc. (HNST)Class Period: purchase of shares issued either in or after the May 2021 Initial Pu

  • Bloomberg

    Bristol-Myers Makes Takeover Approach to Aurinia Pharmaceuticals

    (Bloomberg) -- Bristol-Myers Squibb Co. has expressed interest in acquiring smaller rival biopharmaceutical firm Aurinia Pharmaceuticals Inc., according to people familiar with the matter. Most Read from BloombergWhy Americans and Britons Are Rushing to Buy Idyllic Homes in ItalyThe Top Money Maker at Deutsche Bank Reaps Billions From SingaporeCities' Answer to Sprawl? Go Wild.One of California’s Wealthiest Counties Could Run Out of Water Next SummerHamburg Is at the Heart of Germany’s Growing D